Those 40+ patients are dying now. Maybe 27+ more could be saved. I think it is unethical NOT to be continuing the treatments/Phase 2bTrial. A 2b/3 Trial normally completes the reviews of the 2b then progresses to a Phase 3 with a much larger group for "statistically significant" data. EUA probable, overall approval unlikely, IMHFO...